Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Mian

Neurological Surgery Englewood, CO Medical Doctor

NPI 1154683597 CMS profile 143599

701 E Hampden Ave Ste 110, Ste 110, Englewood, CO 80113

Open in the dashboard

General payments

$61,987

387 records reported · program years 2019–2025

Research payments

$1,650

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Mian of Englewood, CO is reported in the CMS Open Payments database as having received $61,987 across 387 general payments and $1,650 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,908 64
2024 General $15,785 71
2023 General $9,936 39
2022 General $5,723 97
2021 General $2,428 32
2020 General $1,614 33
2020 Research $1,650 1
2019 General $6,593 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Mian
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Matthew Mian were reported at $19,908. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Matthew Mian Neurological Surgery median Middle half National median
2019 $6,593 $582 $138–$3,006 $163
2020 $1,614 $294 $76–$2,174 $114
2021 $2,428 $387 $105–$2,432 $132
2022 $5,723 $542 $139–$2,989 $149
2023 $9,936 $534 $145–$2,697 $160
2024 $15,785 $574 $155–$3,046 $164
2025 $19,908 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NeuroPace, Inc. $24,179 39 payments
  2. Medtronic, Inc. $19,645 149 payments
  3. Medtronic USA, Inc. $6,195 44 payments
  4. Boston Scientific Corporation $4,205 39 payments
  5. Globus Medical, Inc. $2,606 17 payments
  6. Abbott Laboratories $1,902 35 payments
  7. Alphatec Spine, Inc $938 7 payments
  8. InSightec,Inc $699 10 payments
  9. Nevro Corp. $672 12 payments
  10. LivaNova USA, Inc. $357 6 payments
  11. Other $589 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $33,819 18 payments
  2. Food and Beverage $14,192 310 payments
  3. Travel and Lodging $10,851 58 payments
  4. Grant $3,125 1 payment
Products named General payments · program years 2019–2025
  1. RNS Neurostimulator Kit $24,017 37 payments
  2. PERCEPT PC BRAINSENSE $8,508 62 payments
  3. STEALTHSTATION S8 PLATFORM $6,379 5 payments
  4. ACTIVA $5,322 29 payments
  5. ACTIVA PC $1,198 13 payments
  6. Vercise $1,185 7 payments
  7. SenSight $905 35 payments
  8. General - Therapies $675 2 payments
  9. Senza Spinal Cord Stimulation System $645 11 payments
  10. EXABLATE $637 7 payments
  11. Other $9,944 161 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $1,650 1 payment

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$121,687

Medicare's payments for the services billed

Medicare patients

105

Average age 72

Services billed

247

48 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 50%
Depression 40%
Chronic kidney disease 22%
Diabetes 20%
Ischemic heart disease 17%
Heart failure 16%
Osteoporosis 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

388 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record